HomeTOP STORIESAbbVie's Elahere gains approval in Canada for ovarian cancer AbbVie’s Elahere gains approval in Canada for ovarian cancer By rogerjudd September 2, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleTech Voices: Musk on Optimus, OpenAI parent controls, SAP’s IaaS pushNext articleNewmont downgraded to Neutral at Macquarie but shares rise alongside gold price latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
